Related Experiment Videos
Endothelial cell seeding kinetics under chronic flow in prosthetic grafts
1Department of Vascular Surgery, Manchester Royal Infirmary and Medical School, England.
Annals of Vascular Surgery
|September 1, 1996
Summary
This study found fibronectin coating significantly improves human adult endothelial cell adherence and retention on vascular grafts. Hemashield Dacron grafts demonstrated the best cell retention under simulated arterial blood flow.
Area of Science:
- Biomaterials Science
- Vascular Surgery
- Cell Biology
Background:
- Endothelial cell-seeded grafts require robust initial adherence and retention for improved patency.
- Evaluating commercial prostheses for effective endothelial cell seeding is crucial for clinical success.
Purpose of the Study:
- To assess the suitability of expanded polytetrafluoroethylene (ePTFE), Gelseal, and Hemashield grafts for human adult endothelial cell (HAEC) seeding.
- To quantify the impact of fibronectin (FN) coating on HAEC adherence and retention on these grafts under simulated arterial blood flow.
Main Methods:
- Indium-111 oxine labeled HAECs were used to measure adherence to plain and FN-coated ePTFE, Gelseal, and Hemashield grafts.
- Cell retention was quantified over 24 hours in a pulsatile flow model simulating human arterial conditions (200 ml/min).
- Scanning electron microscopy confirmed cell retention qualitatively.
Main Results:
- FN coating significantly enhanced initial HAEC adherence to all tested grafts compared to plain surfaces.
- Dacron grafts (Gelseal and Hemashield) showed better initial adherence than ePTFE, especially when FN-coated.
- After 24 hours of simulated flow, FN-coated Hemashield grafts exhibited the highest cell retention (65%), followed by FN-coated Gelseal (25%) and FN-coated ePTFE (16%).
Conclusions:
- Fibronectin coating is essential for improving endothelial cell seeding on vascular grafts.
- Dacron-based grafts, particularly Hemashield, offer superior cell retention compared to ePTFE when coated with fibronectin.
- These findings support the use of FN-coated Hemashield grafts for enhanced vascular reconstruction.